. Author manuscript; available in PMC: 2020 Aug 11.

Published in final edited form as: Gynecol Oncol. 2019 Apr 16;154(1):72–76. doi: 10.1016/j.ygyno.2019.04.011

Table 5:

Calibration estimates for the predictive model for gross residual disease (RD)

Total predictive value score	Total patients	No gross RD	Gross RD	Observed gross RD rate in the Mayo validation cohort (95% CI)^*	Predicted gross RD rate in the published model development cohort
Total predictive value score	N (%)	N	N
0–2	96/276 (34.8%)	74	22	22.9% (15.0–32.6%)	45%
3–5	108/276 (39.1%)	50	58	53.7% (43.9–63.4%)	68%
6–8	43/276 (15.6%)	6	37	86.1% (72.1–94.7%)	87%
≥9	29/276 (10.5%)	6	23	79.3% (60.3–92.0%)	96%

Exact 95% confidence intervals for a binominal proportion.